Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
- PMID: 37387820
- PMCID: PMC10307419
- DOI: 10.1155/2023/9830309
Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
Abstract
[This retracts the article DOI: 10.1155/2021/9388562.].
Copyright © 2023 Evidence-Based Complementary and Alternative Medicine.
Retraction of
-
Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI.Evid Based Complement Alternat Med. 2021 Oct 15;2021:9388562. doi: 10.1155/2021/9388562. eCollection 2021. Evid Based Complement Alternat Med. 2021. Retraction in: Evid Based Complement Alternat Med. 2023 Jun 21;2023:9830309. doi: 10.1155/2023/9830309. PMID: 34691230 Free PMC article. Retracted.
References
-
- Xue L., Yuan X., Zhang S., Zhao X. Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI. Evidence-Based Complementary and Alternative Medicine . 2021;2021:6. doi: 10.1155/2021/9388562.9388562 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
